Max Healthcare Institute Limited · NSE: MAXHEALTH · BSE: 543220
Max Healthcare Institute
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 13 Aug 2026.
Q1 FY27 · Consolidated
Revenue
2,366.17₹ Cr
+16.7% vs year ago
Net profit
322.96₹ Cr
+4.9% vs year ago
EPS, basic
3.32₹
+4.7% vs year ago
Net margin
13.6%
−1.5 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 2,366.17 | +16.7% | 322.96 | +4.9% | 3.32 | 13 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 2,142.89 | +12.2% | 342.22 | +7.3% | 3.52 | 21 May 2026 |
| Q3 FY26Oct–Dec 2025 | 2,067.52 | +10.7% | 300.92 | +26.0% | 3.10 | 05 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 2,135.47 | +25.1% | 491.30 | +74.3% | 5.05 | 14 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 2,027.57 | +31.4% | 307.97 | +30.3% | 3.17 | 13 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 1,909.74 | +34.2% | 319.00 | +26.8% | 3.28 | 20 May 2025 |
| Q3 FY25Oct–Dec 2024 | 1,868.31 | +40.0% | 238.80 | −17.5% | 2.46 | 30 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 1,707.46 | +25.3% | 281.81 | +1.9% | 2.90 | 05 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 1,542.95 | +20.1% | 236.27 | −1.6% | 2.43 | 02 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 1,422.90 | +17.2% | 251.54 | +0.2% | 2.59 | 23 May 2024 |
| Q3 FY24Oct–Dec 2023 | 1,334.97 | +17.0% | 289.34 | +30.1% | 2.98 | 31 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 1,363.16 | +19.9% | 276.68 | −39.5% | 2.85 | 07 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 1,284.99 | +20.5% | 240.08 | +38.9% | 2.47 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 1,214.51 | +29.4% | 250.92 | +102.8% | 2.58 | 17 May 2023 |
| Q3 FY23Oct–Dec 2022 | 1,141.24 | +17.2% | 222.41 | +17.2% | 2.29 | 02 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 1,137.12 | +11.7% | 457.35 | +216.2% | 4.72 | 01 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 1,066.27 | +6.6% | 172.83 | +17.6% | 1.78 | 11 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 938.80 | +17.1% | 123.73 | +77.5% | 1.28 | 26 May 2022 |
| Q3 FY22Oct–Dec 2021 | 974.16 | +22.4% | 189.75 | +110.0% | 1.96 | 12 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 1,018.33 | +56.4% | 144.65 | 11x | 1.50 | 17 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 1,000.17 | — | 146.92 | — | 1.52 | 11 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 801.86 | — | 69.69 | — | 0.76 | 29 May 2021 |
| Q3 FY21Oct–Dec 2020 | 795.60 | — | 90.36 | — | 1.00 | 06 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 650.94 | — | 13.11 | — | 0.16 | 16 Nov 2020 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 782.92 | +12.8% | 167.60 | +0.9% | 1.72 | 13 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 732.90 | +11.3% | 203.21 | +14.6% | 2.09 | 21 May 2026 |
| Q3 FY26Oct–Dec 2025 | 710.91 | +1.9% | 186.95 | +35.2% | 1.92 | 05 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 736.62 | +7.4% | 160.42 | −30.6% | 1.65 | 14 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 694.02 | +11.7% | 166.03 | +7.7% | 1.71 | 13 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 658.70 | +8.0% | 177.39 | −26.6% | 1.82 | 20 May 2025 |
| Q3 FY25Oct–Dec 2024 | 697.40 | +18.1% | 138.24 | −12.6% | 1.42 | 30 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 686.11 | +15.0% | 231.30 | +43.4% | 2.38 | 05 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 621.39 | +14.3% | 154.14 | +22.3% | 1.59 | 02 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 610.11 | +20.3% | 241.77 | +91.3% | 2.49 | 23 May 2024 |
| Q3 FY24Oct–Dec 2023 | 590.75 | +22.6% | 158.12 | +29.5% | 1.63 | 31 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 596.87 | +25.9% | 161.31 | −55.0% | 1.66 | 07 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 543.63 | +27.4% | 126.06 | +47.9% | 1.30 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 507.32 | +33.1% | 126.37 | +91.0% | 1.30 | 17 May 2023 |
| Q3 FY23Oct–Dec 2022 | 481.97 | +21.2% | 122.14 | +17.7% | 1.26 | 02 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 474.14 | +5.4% | 358.64 | +389.6% | 3.70 | 01 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 426.55 | −14.7% | 85.26 | −3.0% | 0.88 | 11 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 381.20 | +15.2% | 66.15 | +813.7% | 0.68 | 26 May 2022 |
| Q3 FY22Oct–Dec 2021 | 397.72 | +14.9% | 103.81 | +229.0% | 1.07 | 12 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 449.95 | +59.6% | 73.25 | +602.3% | 0.76 | 17 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 500.21 | — | 87.92 | — | 0.91 | 11 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 330.80 | — | 7.24 | — | 0.08 | 29 May 2021 |
| Q3 FY21Oct–Dec 2020 | 346.13 | — | 31.55 | — | 0.35 | 06 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 281.93 | — | 10.43 | — | 0.12 | 16 Nov 2020 |
48 filings on record for this company.